INTRODUCTION
============

The demand for total knee arthroplasty (TKA) is rapidly rising in light of the prevalence of arthritis and obesity in an ageing population\[[@R1],[@R2]\]. The number of total knee replacements increased by more than 275,000 procedures from 2004 to 2010 in the United States\[[@R3],[@R4]\].The Center for Disease Control (CDC) data on inpatient surgical procedures in the US presents a clear indication of the growing burden of total knee arthroplasty on overall health costs. A total of 719,000 TKA procedures were performed in 2010, more thandouble the number of total hip replacements \[[@R4]\]. At an average cost of 17,000 USD per procedure, this amounts for a total cost of more than 11.5 billion USD in one year \[[@R5]\].

In addition to the price of the implant, procedure costs are incurred through hospital stay and post-operative rehabilitation. The CDC reports average length of stay data according to age group and diagnosis for the years 1990, 2000, and 2010 \[[@R6]\]. The data includes total joint replacement under the broad category of osteoarthritis without differentiating between hip and knee procedures. Among patients between 45 and 64 years of age, the average length of stay decreased from 7.4 days in 1990, to 3.9 days in 2000 and 3.3 days in 2010. This duration increases with age to 9.3 days (1990), 4.7 days (2000), and 3.6 days (2010) for patients between 65 and 74 years old and reaches 10.5 days (1990), 4.7 days (2000), and 3.9 days (2010) among patients older than 85 years. The data also reveals statistically significant longer hospital stay for female patients as compared to males \[[@R6]\].

The projected increase to 3.5 million annual knee replacement procedures in the US by 2030 will considerably strain hospital facilities and resources \[[@R1]\].The total cost of these procedures is driven primarily by cost of joint implants, length of stay, and operating room time. Multimodal clinical pathways have emerged in an attempt to reduce length of stay without increasing post-operative complications. Such "fast-track" pathways focus on patient education, pre-operative discharge planning, pre-emptive pain and nausea management, and accelerated rehabilitation \[[@R7]-[@R10]\]. Several variables have associated with a longer duration of hospitalization, namely patient age, comorbidities and American Society of Anesthesiologists (ASA) score, obesity, operative time, type of anesthesia, preoperative anemia, and blood transfusion \[[@R11]-[@R13]\]. Patient blood management addresses preoperative anemia and the associated risk of allogeneic transfusion, both of which are independently associated with adverse outcomes including increased postoperative mortality and morbidity. As such, blood management is one of the most modifiable factors that might significantly impact length of stay \[[@R14]-[@R18]\]. The current study investigates the impact of patient factors, surgical factors, and blood management on postoperative length of stay in patients who underwent primary total knee arthroplasty.

MATERIALS AND METHODS
=====================

We conducted a retrospective review of 516 primary total knee replacement procedures performed between 2009 and 2012 by one of five surgeons at the authors' institution. Patients with a preoperative hemoglobin (Hb) level below 13.5 g/dL were considered anemic and were advised to donate one unit of autologous blood 7 to 15 days prior to the date of surgery. No patient was allowed to donate less than 7 days prior to the procedure and daily oral iron supplementation was given until the day of the surgery. Patients received allogeneic transfusions if their hemoglobin level dropped below 8.0 g/dL and they displayed clinical symptoms of anemia (tachycardia and/or hypotension) despite an intravenous fluid bolus. The decision to transfuse autologous blood was made at the discretion of the anesthesiologist and medical attending, and strict transfusion guidelines were not enforced.

Gender, age, body mass index (BMI), preoperative Hb, autologous blood donation, number of autologous transfusions, number of allogeneic transfusions, postoperative Hb levels until date of discharge, and in-house complications were recorded. Length of stay was calculated as the number of days in hospital from the day of surgery to the day of discharge, with day of surgery being day 0. Patients who underwent revision TKA, simultaneous bilateral TKA, and patients with bleeding disorders were excluded. The study was approved by the Institutional Review Board at the authors' institution.

All procedures were performed under hypotensive spinal--epidural anesthesia using a standardized medial parapatellar approach in TKA with the use of a tourniquet. 177 procedures were performed on males and 339 on females, with a mean age of 66 years at the time of the surgery (range: 27--90 years) and BMI of 30.3 kg/m^2^ (range: 12.7--74.7 kg/m^2^) (Table **[1](#T1){ref-type="table"}**). Patients were divided by BMI into groups according to the World Health Organization (WHO) criteria; underweight (\< 18.5 kg/m^2^), normal weight

(18.5 kg/m^2^ to 24.9 kg/m^2^), over-weight (25 kg/m^2^ to 29.9 kg/m^2^) and obese (\> 30 kg/m^2^). Patients with BMI greater than 30 kg/m^2^ were further subdivided into 3 groups, 30 to 34.9 kg/m^2^, 35 to 39.9 kg/m^2^, and 40 kg/m^2^ or more.

Descriptive statistics were used to illustrate patient demographics and health characteristics. Medians and the 25th and the 75th percentiles were calculated for length of stay, means and standard deviations were calculated for continuous variables, and frequency distributions for categorical variables. Inferential statistics (Kruskal-Wallis test, Wilcoxon Rank Sum, or Pearson's Chi-square as appropriate) were used to assess statistical significance among study variables. Poisson regression was performed to identify significant factors influencing LOS. All analyses were conducted using SAS for Windows 9.2 (SAS Institute Inc., Cary, NC, USA). All tests were two-sided and a critical p-value of 0.05 was set for all comparisons (Fig.**[1](#F1){ref-type="fig"}**).

RESULTS
=======

The mean duration of hospital stay for all the patients was 3.9 days with a range of 1 to 13 days. The median LOS was 4 days with an inter-quartile range (i.e. 25th and 75th percentile) of 3 to 4 days. Tables **[1](#T1){ref-type="table"}-[3](#T3){ref-type="table"}** display the individual categories for each factor, the number of cases in each category and the mean length of stay.

Patient characteristics that were found to be highly significant predictors of an increased LOS when considered independently were age and gender, but not BMI or laterality. Surgical factors influencing length of stay included the weekday of surgery, the type of anticoagulation, and the orthopedic surgeon. In terms of blood management, transfusion of allogeneic blood and the number of allogeneic units transfused significantly increased length of stay, whereas donation and/or transfusion of autologous blood did not.Patient hemoglobin levels preoperatively until 48 hours after the procedurewere found to be negatively correlated with LOS.There is no correlation between length of stay and hemoglobin levels at discharge. When adjusted for the effect of confounding factors through Poisson regression, patient age (OR = 1.01, 95% CI = 1.001 to 1.01, p = 0.001)and allo-geneic blood transfusion (OR = 1.18, 95% CI = 1.03 to 1.36, p = 0.002) were found to be the most significant determi-nants of length of stay (Tables **[1](#T1){ref-type="table"}-[3](#T3){ref-type="table"}**).

DISCUSSION
==========

The growing demand for TKA highlights the need to reduce costs without affecting postoperative outcomes, prolonging rehabilitation, or increasing adverse events and readmission rates. Our findings suggest that patient age and blood management have the most significant impact on patients' duration of hospital stay after primary unilateral TKA. LOS has been reported to increase by 10% to 13% with every decade added to the age of the patient as a function of increased co-morbidities and decreased physiologic fitness \[[@R17]\]. This is in accordance with other studies as the effect of age on postoperative hospital stay is well established in the literature \[[@R13],[@R19]-[@R21]\]. Males had a significantly shorter stay in the univariate analysis but the difference did not remain significant when corrected for other variables.

Several studies have identified the importance of blood management as a modifiable factor that influences postoperative hospital stay \[[@R17],[@R18],[@R20]-[@R22]\]. Guerin *et al.* concluded that the preoperative hemoglobin level was the only variable that independently predicts the need for blood transfusion after primary joint arthroplasty \[[@R22]\]. In a study of 2106 primary unilateral total knee procedures, Smith *et al.* found an increased length of stay of one day on average between patients with preoperative Hb less than 12 g/dL compared to patients with Hb greater than 13 g/dL \[[@R17]\].Furthermore, Husted *et al.* identified allogeneic blood transfusion as the most important predictor of discharge around the third day of admission in a fast-track streamlined practice. The data showed a three-fold increased risk of staying more than 3 days whenever a patient is transfused \[[@R13]\]. Our data reveals that the transfusion of allogeneic blood has a greater effect on delaying patient discharge after primary TKA than gender, BMI, hemoglobin levels, anticoagulation protocol, surgeon, or day of surgery.

Variations in practice and rehabilitation protocols between countries have led to a wide disparity in postoperative hospital stay, ranging from 3.8 days in the United States \[[@R23]\], to 10 days in Germany \[[@R24]\], 24 days in France \[[@R25]\], and 35 days in Japan \[[@R26]\].The elective nature of TKA makes it possible to anticipate significant blood loss and individualize patient blood management. Simple measures such as optimizing patient preoperative status and enforcing strict allogeneic transfusion guidelines can significantly reduce morbidity, costs, and length of stay. Correcting preoperative anemia with iron and/or erythropoiesis-stimulating agents can help to decrease transfusion risk. Tranexamic acid \[[@R27]\], fibrin sealants \[[@R28], [@R29]\], blood salvage \[[@R30]\], and hypotensive anesthesia have proven to be safe and efficient in reducing operative blood loss and exposure to allogeneic blood \[[@R31]\].Autologous blood remains one of the safest alternatives to minimize exposure to allogeneic blood \[[@R32]\].Targeting anemic patients for preoperative autologous blood donation was shown to decrease transfusion risk in primary TKA with minimal wastage rates and cost \[[@R33]\]. Donation or transfusion of one autologous blood unit showed no correlation with longer hospital stay in this TKA cohort.

This study is limited by its retrospective nature which restricted obtaining pooled preoperative knee scores and ASA scores in addition to information on complications and readmission rates. Moreover, the threshold of 13.5 g/dL employed in this study for autologous blood donation is based on previous data from our institution on maximizing the benefit and reducing number of units wasted in TKA \[[@R33]\]. Most studies in the literature rely on the World Health Organization definition for anemia of Hb level less than 13 g/dL in males and 12 g/dL in females.

CONCLUSION
==========

Adapting to the increased demand for total knee arthroplasty requiresa cost-effective approach that prioritizes patient safety. Inevitably, higher costs are incurred when patients remain in hospital for longer periods of time after the procedure. Although the difference in the mean length of stay between categories of significant variables is sometimes less than half a day and may not be significant in an individual patient, it would give rise to a significant cost over time. Preoperative optimization of Hb level, employing blood management techniques, and adopting strict transfusion criteria can significantly reduce hospital stay and overall cost of total knee replacement procedures.
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###### 

Demographic factors of patients in the study.

  Factor          Number        Mean LOS    Median LOS  \[25th Percentile, 75th Percentile\]   *p*-Value
  --------------- ------------- ----------- -------------------------------------------------- ------------
  Age (yrs)                                                                                    
  \< 60           129 (25.0%)   3.7 ± 1.0   3 \[3, 4\]                                         0.0017\*
  60-69           197 (38.2%)   3.8 ± 1.1   4 \[3, 4\]                                          
  70-79           144 (27.9%)   4.1 ± 1.4   4 \[3, 4\]                                          
  ≥ 80            46 (8.9%)     4.4 ± 1.9   4 \[3, 5\]                                          
  Gender                                                                                       
  Male            177 (34.3%)   3.7 ± 1.2   4 \[3, 4\]                                         0.0008\*\*
  Female          339 (65.7%)   4.0 ± 1.3   4 \[3, 4\]                                         * *
  Laterality                                                                                   
  Left            265 (51.4%)   4.0 ± 1.4   4 \[3, 4\]                                         0.2344\*\*
  Right           251 (48.6%)   3.8 ± 1.1   4 \[3, 4\]                                         * *
  BMI (kg/m2) †                                                                                
  \< 18.5         1 (0.2%)      4           4 \[4, 4\]                                         0.1012\*
  18.5-24.9       91 (17.7%)    3.7 ± 0.9   4 \[3, 4\]                                          
  25-29.9         194 (37.7%)   4.0 ± 1.4   4 \[3, 4\]                                          
  30-34.9         123 (23.9%)   3.8 ± 0.8   4 \[3, 4\]                                          
  35-39.9         73 (14.2%)    4.0 ± 1.5   4 \[3, 4\]                                          
  ≥ 40            32 (6.2%)     4.6 ± 1.7   4 \[4, 5\]                                          

Obtained from Kruskal-wallis test.

Obtained from Wilcoxon rank-sum test.

Some missing data.

###### 

The effect of hemoglobin level and blood transfusions on LOS.

  Factor                            Number        Mean LOS    Median LOS   *p*-Value
  --------------------------------- ------------- ----------- ------------ ------------
  Preoperative Hb (g/dL)                                                   
  \< 12                             61 (12%)      4.2 ± 1.5   4 \[3, 4\]   0.0013\*
  12-12.9                           111 (22%)     3.9 ± 0.8   4 \[3, 4\]    
  13-13.9                           151 (30%)     4.0 ± 1.3   4 \[3, 4\]    
  ≥ 14                              193 (37%)     3.7 ± 1.3   4 \[3, 4\]    
  Postoperative Hb (g/dL)                                                  
  \< 12                             261 (51%)     4.0 ± 1.2   4 \[3, 4\]   0.001\*
  12-12.9                           145 (28%)     3.9 ± 1.5   4 \[3, 4\]    
  13-13.9                           77 (15%)      3.7 ± 1.3   3 \[3, 4\]    
  ≥ 14                              33 (6%)       3.5 ± 0.9   3 \[3, 4\]    
  Autologous blood                                                         
  Did not donate                    424 (82.2%)   3.9 ± 1.3   4 \[3, 4\]   0.8591\*\*
  Donate                            92 (17.8%)    3.9 ± 0.9   4 \[3, 4\]   * *
  Blood transfusion                                                        
  None                              413 (80.0%)   3.8 ± 1.1   4 \[3, 4\]   0.003\*
  Autologous only                   41 (7.9%)     3.8 ± 0.8   4 \[3, 4\]    
  Allogeneic only                   55 (10.7%)    4.7 ± 2.1   4 \[3, 5\]    
  Autologous + Allogeneic           7 (1.4%)      5.0 ± 1.7   4 \[4, 6\]    
  \# of Allogeneic units received                                          
  0                                 454 (88.0%)   3.8 ± 1.1   4 \[3, 4\]   0.0014\*
  1                                 47 (9.1%)     4.7 ± 2.2   4 \[3, 5\]    
  2                                 11 (2.1%)     4.3 ± 1.0   4 \[4, 5\]    
  3                                 3 (0.6%)      7.0 ± 2.7   8 \[4, 9\]    
  4                                 1 (0.2%)      3           3 \[3, 3\]    

Obtained from Kruskal-wallis test.

Obtained from Wilcoxon rank-sum test.

###### 

Surgical factors of patients in the study.

  Factor                                 Number        Mean LOS    Median LOS \[25th Percentile, 75th Percentile\]   *p*-Value
  -------------------------------------- ------------- ----------- ------------------------------------------------- ------------
  Surgeon - TKA                                                                                                      
  1                                      17 (3.3%)     3.1 ± 0.9   3 \[3, 3\]                                        \<0.0001\*
  2                                      357 (69.2%)   4.0 ± 1.4   4 \[3, 4\]                                         
  3                                      32 (6.2%)     3.7 ± 1.2   3 \[3, 4\]                                         
  4                                      8 (1.6%)      4.0 ± 0.8   4 \[4, 5\]                                         
  5                                      102 (19.8%)   3.7 ± 1.0   4 \[3, 4\]                                         
  Day of operation                                                                                                   
  Monday                                 7 (1.4%)      2.9 ± 1.1   3 \[2, 4\]                                        0.0002\*
  Tuesday                                43 (8.3%)     3.8 ± 1.5   3 \[3, 4\]                                         
  Wednesday                              69 (13.4%)    4.0 ± 1.3   4 \[3, 4\]                                         
  Thursday                               97 (18.8%)    3.8 ± 1.0   4 \[3, 4\]                                         
  Friday                                 230 (44.6%)   4.1 ± 1.4   4 \[3, 4\]                                         
  Saturday                               70 (13.6%)    3.6 ± 0.8   4 \[3, 4\]                                         
  Anticoagulation                                                                                                    
  None                                   4 (0.8%)      4.3 ± 0.5   4 \[4, 5\]                                        \<0.0001\*
  Aspirin                                45 (8.7%)     3.4 ± 0.9   3 \[3, 4\]                                         
  Aspirin + Coumadin                     73 (14.1%)    4.0 ± 1.4   4 \[3, 4\]                                         
  Aspirin + Coumadin + Lovenox/Heparin   5 (1.0%)      5.4 ± 2.1   5 \[4, 5\]                                         
  Aspirin + Lovenox/Heparin              1 (0.2%)      3           3 \[3, 3\]                                         
  Coumadin                               376 (72.9%)   3.9 ± 1.2   4 \[3, 4\]                                         
  Coumadin + Lovenox/Heparin             11 (2.1%)     5.4 ± 2.4   4 \[4, 6\]                                         
  Lovenox                                1 (0.2%)      3           3 \[3, 3\]                                         

Obtained from Kruskal-wallis test.
